EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies

Autor Tremblay-LeMay, Rosemarie, Rastgoo, Nasrin, Pourabdollah, Maryam, Chang, Hong
Vydáno v Biomark Res (2018)

High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide

Autor Pourabdollah, Maryam, Bahmanyar, Mohammad, Atenafu, Eshetu G., Reece, Donna, Hou, Jian, Chang, Hong
Vydáno v J Hematol Oncol (2016)

Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma

Autor Rastgoo, Nasrin, Wu, Jian, Liu, Aijun, Pourabdollah, Maryam, Atenafu, Eshetu G., Reece, Donna, Chen, Wenming, Chang, Hong
Vydáno v Haematologica (2019)